Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-3002 (Growtropin) vs Genotropin in Turner Syndrome
NCT01813630Phase 3Completed
- Sponsor
- Dong-A ST
- Start
- Feb 2013
- Primary completion
- May 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Growtropin-II in Turner syndrome (TS), sponsored by Dong-A ST. Started Feb 2013; status: completed.
02
Drugs
Growtropin-II
03
Conditions
Turner syndrome (TS)
Beyond the preview
Go deeper on NCT01813630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01813630.